333 related articles for article (PubMed ID: 2884861)
1. Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension.
Trost BN; Weidmann P; Riesen W; Claessens J; Streulens Y; Nelemans F
Am J Cardiol; 1987 May; 59(14):99G-104G. PubMed ID: 2884861
[TBL] [Abstract][Full Text] [Related]
2. An open one-year comparison of doxazosin and prazosin for mild to moderate essential hypertension.
Torvik D; Madsbu HP
Am J Cardiol; 1987 May; 59(14):68G-72G. PubMed ID: 2884855
[TBL] [Abstract][Full Text] [Related]
3. A 24-week multicenter double-blind study of doxazosin and hydrochlorothiazide in patients with mild to moderate essential hypertension.
Hjortdahl P; von Krogh H; Daae L; Holme I; Hjermann I
Acta Med Scand; 1987; 221(5):427-34. PubMed ID: 2955672
[TBL] [Abstract][Full Text] [Related]
4. Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension.
Frick MH; Cox DA; Himanen P; Huttunen M; Pitkäjärvi T; Pörsti P; Pöyhönen L; Pyykönen ML; Reinikainen P; Salmela P
Am J Cardiol; 1987 May; 59(14):61G-67G. PubMed ID: 2884854
[TBL] [Abstract][Full Text] [Related]
5. The antihypertensive effects of doxazosin: a clinical overview.
Cox DA; Leader JP; Milson JA; Singleton W
Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):83S-90S. PubMed ID: 2939872
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients.
Talseth T; Westlie L; Daae L; Vatle S
Am Heart J; 1988 Dec; 116(6 Pt 2):1790-6. PubMed ID: 2904752
[TBL] [Abstract][Full Text] [Related]
7. Alpha-blockade and thiazide treatment of hypertension. A double-blind randomized trail comparing doxazosin and hydrochlorothiazide.
Grimm RH; Flack JM; Schoenberger JA; Gonzalez NM; Liebson PR
Am J Hypertens; 1996 May; 9(5):445-54. PubMed ID: 8735175
[TBL] [Abstract][Full Text] [Related]
8. Alpha-1 adrenoceptor blockade with doxazosin in hypertension: effects on blood pressure and lipoproteins.
Ames RP; Kiyasu JY
J Clin Pharmacol; 1989 Feb; 29(2):123-7. PubMed ID: 2565917
[TBL] [Abstract][Full Text] [Related]
9. Multicentre 12-week double-blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension.
Torvik D; Madsbu HP
Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):69S-75S. PubMed ID: 2939870
[TBL] [Abstract][Full Text] [Related]
10. A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension.
Frick MH; Halttunen P; Himanen P; Huttunen M; Pörsti P; Pitkäjärvi T; Pöyhönen L; Pyykönen ML; Reinikainen P; Salmela P
Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):55S-62S. PubMed ID: 2939868
[TBL] [Abstract][Full Text] [Related]
11. A double-blind comparative study of doxazosin and nitrendipine in patients with mild-to-moderate essential hypertension.
Nechwatal W; Berger J; Blumrich W; Bouzo H; Brandl K; Braun S; Laukaitis A; Müller G; Ryba W; Schreiegg J
Am Heart J; 1988 Dec; 116(6 Pt 2):1806-14. PubMed ID: 2904755
[TBL] [Abstract][Full Text] [Related]
12. A double-blind parallel trial to assess the efficacy of doxazosin, atenolol and placebo in patients with mild to moderate systemic hypertension.
Nash DT; Schonfeld G; Reeves RL; Black H; Weidler DJ
Am J Cardiol; 1987 May; 59(14):87G-90G. PubMed ID: 2884859
[TBL] [Abstract][Full Text] [Related]
13. Doxazosin in the treatment of patients with mild or moderate hypertension and mild or moderate renal insufficiency.
Bartels AC; de Vries PM; Oe LP; van Bronswÿk H; Donker AJ; Réveillaud RJ; Fillastre JP; Zech P
Am Heart J; 1988 Dec; 116(6 Pt 2):1772-7. PubMed ID: 2904749
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with doxazosin in general medical practice.
Rosenthal J
Am Heart J; 1988 Dec; 116(6 Pt 2):1748-57. PubMed ID: 2904745
[TBL] [Abstract][Full Text] [Related]
15. A single-blind study of doxazosin in the treatment of mild-to-moderate essential hypertensive patients with concomitant noninsulin-dependent diabetes mellitus.
Castrignano R; D'Angelo A; Pati T; Al Awady M; Tronca R; Crepaldi G
Am Heart J; 1988 Dec; 116(6 Pt 2):1778-84. PubMed ID: 2904750
[TBL] [Abstract][Full Text] [Related]
16. Multicenter, double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
Ott P; Storm TL; Krusell LR; Jensen H; Badskjaer J; Faergeman O
Am J Cardiol; 1987 May; 59(14):73G-77G. PubMed ID: 2884856
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of doxazosin versus atenolol in mild-to-moderate hypertension.
Giorgi G; Legramante JM; Fioravanti G; Paies G; Legramante A
Am Heart J; 1988 Dec; 116(6 Pt 2):1801-5. PubMed ID: 2904754
[TBL] [Abstract][Full Text] [Related]
18. Doxazosin versus atenolol: a randomized comparison of calculated coronary heart disease risk reduction.
Mazzola C; Guerrasio E
Am Heart J; 1988 Dec; 116(6 Pt 2):1797-801. PubMed ID: 2904753
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of doxazosin in hypertension therapy.
Hayduk K
Am J Cardiol; 1987 May; 59(14):35G-39G. PubMed ID: 2884851
[TBL] [Abstract][Full Text] [Related]
20. Reduction of left ventricular hypertrophy after longterm antihypertensive treatment with doxazosin.
Agabiti-Rosei E; Muiesan ML; Rizzoni D; Zulli R; Calebich S; Beschi M; Castellano M; Muiesan G
J Hum Hypertens; 1992 Feb; 6(1):9-15. PubMed ID: 1349920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
